Trial of Dasatinib in Advanced Sarcomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00464620
Recruitment Status : Active, not recruiting
First Posted : April 23, 2007
Last Update Posted : March 22, 2017
Bristol-Myers Squibb
Information provided by (Responsible Party):
Sarcoma Alliance for Research through Collaboration

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : December 2016
  Estimated Study Completion Date : May 2017